Is IQMX a Buy? What to Consider in 2026
Short answer
The bull case for IQM Quantum Computers Oyj (IQMX) rests on On-premise superconducting hardware: IQM sells and installs complete superconducting quantum computers that customers host themselves, rather than renting cloud access. Revenue (2025) is ~$36 million (about 31 million euros). If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Quantum computing is unproven as a broad commercial market and may take many years to deliver clear advantage over classical computers on real workloads. Whether IQMX is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
IQM Quantum Computers Oyj (IQMX) builds full-stack superconducting quantum computers, the physical machines plus the control electronics and software that run them. Founded in 2018 and headquartered in Espoo, Finland, IQM sells and installs systems on-premise, most notably to national supercomputing centers and research institutions, and reported around 23 systems sold with a European backlog of more than 60 million euros as of mid-2026. Its differentiation is a co-design and on-premise delivery model, tailoring machines for specific customers and letting them host the hardware themselves, in contrast to peers that emphasize cloud access. The company listed on the Nasdaq Global Select Market in July 2026 by merging with Real Asset Acquisition Corp, becoming the first European quantum computing firm on a major US exchange. The investment picture is speculative. IQM produced roughly 36 million dollars of revenue in 2025 while posting an operating loss around 56 million dollars, and it funds heavy research and development from capital raised privately and now in public markets, including a 300 million dollar Series B in 2025. At a market value near 2.7 billion dollars (asOf July 2026) against tiny sales, IQMX trades at an extreme multiple that reflects hope about future quantum advantage, not present cash flow. As a fresh de-SPAC in an unproven, hype-prone sector, the stock is likely to be volatile and sensitive to milestones, sentiment, and funding news rather than fundamentals.
What's the case for buying IQMX?
1. On-premise superconducting hardware.
IQM sells and installs complete superconducting quantum computers that customers host themselves, rather than renting cloud access. This model appeals to national labs, universities, and government-backed supercomputing centers that want physical control, data sovereignty, and integration with existing high-performance computing infrastructure. It has produced actual hardware revenue and a delivery track record ahead of many pure-play peers.
2. Real revenue and backlog.
Unlike some quantum startups with negligible sales, IQM reported roughly 36 million dollars of revenue in 2025 and an order backlog above 60 million euros, with around 23 systems sold and 18 delivered globally (asOf July 2026). That commercial traction, concentrated in European public-sector buyers, gives IQM a more tangible base than a pre-revenue concept, though the figures remain small relative to its valuation.
3. Well-funded balance sheet.
The SPAC merger added a pro forma cash position of roughly 337 million euros, on top of a 300 million dollar Series B raised in 2025, leaving IQM with more than 450 million dollars of cash by its own account (asOf July 2026). A large cash runway matters for a company burning money on research, because it reduces near-term financing pressure and buys time to pursue technical milestones.
4. European quantum positioning.
IQM is the first European quantum computing company to list on a major US exchange, and it benefits from European government and EU-level funding programs aimed at building sovereign quantum capability. That regional demand base is a potential differentiator versus US-centric rivals, and it positions IQM as a flagship name for investors seeking European deep-tech exposure.
What are the risks to IQMX?
Quantum computing is unproven as a broad commercial market and may take many years to deliver clear advantage over classical computers on real workloads. IQM has small revenue, large operating losses, and burns cash on research, so it depends on capital markets and could dilute shareholders. As a recent de-SPAC, it carries the added risks of that structure, including potential share overhang, limited trading history, and a valuation set in a deal rather than by an open IPO book. Competition is intense and includes far larger firms (IBM, Google, Microsoft, Amazon) and better-known public pure plays. Revenue is concentrated in European public-sector buyers, and the stock is likely to be highly volatile and sentiment-driven, with real risk of permanent capital loss.
How is IQMX valued? (as of July 2026)
Snapshot for IQMX as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (2025): ~$36 million (about 31 million euros)
- Profitability: Not profitable; operating loss ~$56 million in 2025
- Order backlog: ~60 million euros or more
- Cash position: ~$450 million or more after the SPAC merger and 2025 Series B
- Market cap: ~$2.7 billion (highly variable; verify current figure)
- Dividend: None
IQMX cannot be valued on earnings because it has none; the stock trades on the option value of quantum computing eventually becoming commercially important. Its price-to-sales multiple is extreme, above 70 times trailing revenue at a market value near 2.7 billion dollars, and it swings sharply with risk appetite. Treat any IQMX valuation as a speculative, scenario-driven estimate and verify the latest revenue, cash, and share count before drawing conclusions.
How do you decide if IQMX is a buy?
Rather than asking whether IQMX is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold IQMX indirectly through an index or sector ETF before adding more.
For the full picture, see the IQMX stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about IQMX against your real portfolio and see your actual exposure before deciding.
The bottom line on IQMX
The bottom line: IQM Quantum Computers Oyj's story right now is On-premise superconducting hardware, with revenue (2025) at ~$36 million (about 31 million euros). If you believe that narrative continues, the call is about sizing IQMX sensibly and checking overlap with what you own; if you doubt it (the risk: quantum computing is unproven as a broad commercial market and may take many years to deliver clear advantage over classical computers on real workloads.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around IQMX with Walnut
Use IQM Quantum Computers Oyj as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is IQMX a good stock to buy right now?
+
The case for IQM Quantum Computers Oyj right now is On-premise superconducting hardware, with revenue (2025) at ~$36 million (about 31 million euros). If you believe that thesis holds, IQMX is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is quantum computing is unproven as a broad commercial market and may take many years to deliver clear advantage over classical computers on real workloads. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does IQM Quantum Computers Oyj do?
+
IQM Quantum Computers Oyj (IQMX) builds full-stack superconducting quantum computers, the physical machines plus the control electronics and software that run them.
What are the main risks of IQMX?
+
Quantum computing is unproven as a broad commercial market and may take many years to deliver clear advantage over classical computers on real workloads. IQM has small revenue, large operating losses, and burns cash on research, so it depends on capital markets and could dilute shareholders. As a recent de-SPAC, it carries the added risks of that structure, including potential share overhang, limited trading history, and a valuation set in a deal rather than by an open IPO book. Competition is intense and includes far larger firms (IBM, Google, Microsoft, Amazon) and better-known public pure plays. Revenue is concentrated in European public-sector buyers, and the stock is likely to be highly volatile and sentiment-driven, with real risk of permanent capital loss.
What is IQMX's ticker symbol and what company is it?
+
IQMX is IQM Quantum Computers Oyj, a Finnish full-stack superconducting quantum computing company headquartered in Espoo. Its American Depositary Shares began trading on the Nasdaq Global Select Market in July 2026 after a SPAC merger with Real Asset Acquisition Corp.
What does IQM Quantum Computers do?
+
IQM builds complete superconducting quantum computers, including the hardware, control electronics, and software. It sells and installs these systems on-premise, mainly to national supercomputing centers, universities, and research institutions, rather than offering only cloud access like some competitors.
Is IQMX profitable?
+
No. IQM generated roughly 36 million dollars of revenue in 2025 but reported an operating loss around 56 million dollars. It burns cash funding research and development, which is typical for an early-stage company in an emerging technology field, and it is not expected to be profitable in the near term.
Is IQMX a speculative stock?
+
Yes. IQMX is a pure-play bet on quantum computing, a technology that may take many years to reach broad commercial value. As a recent de-SPAC with tiny revenue relative to its valuation, the stock is likely to be highly volatile and driven by sentiment, milestones, and funding news. There is real risk of permanent capital loss.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell IQMX; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.